Cloud Banner

Pharmaceutical

Image

Global Radiopharmaceuticals Market - Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Jun 2023
  • Global
  • 350 Pages
  • No of Tables: 1211
  • No of Figures: 65

Global Radiopharmaceuticals Market, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnosticand Therapeutic), Source (Nuclear Reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others) - Industry Trends and Forecast to 2030.

Radiopharmaceuticals Market

Radiopharmaceuticals Market Analysis and Insights

The increasing awareness about radiopharmaceuticals globally has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the markets’ growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in improved advancement of drug development techniques also contributes to the rising demand for radiopharmaceuticals.

Radiopharmaceuticals MarketRadiopharmaceuticals Market

The global radiopharmaceuticals market is expected to grow due to the rise in market players and the availability of advanced services. With this, manufacturers are engaged in the developmental activity for launching novel services in the market. The increasing growth in the field of drug development is further boosting the market growth. However, difficulties such as the lack of standardized protocols and the lack of skilled professionals are expected to hamper the global radiopharmaceuticals market growth.

The increasing healthcare expenditure on advancement and drug development is expected to give opportunities to the market. However, the growing use of alternative treatments may challenge the market growth. Various companies are taking initiatives that gradually lead to market growth.

Data Bridge Market Research analyzes that the global radiopharmaceuticals market is expected to reach a value of USD 15,317.05 million by 2030, at a CAGR of 6.5% during the forecast period of 2023-2030.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015 – 2020)

Quantitative Units

Revenue in USD Million

Segments Covered

By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnosticand Therapeutic), Source (Nuclear Reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand,  Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and rest of Middle East and Africa

Market Players Covered

Cardinal Health, Advanced Accelerator Applications, A Novartis Company, Lantheus, Curium, GE HealthCare, Jubilant Radiopharma, A Jubilant Pharma Company, China lsotope & Radiation Corporation., Siemens Healthcare GmbH, Bracco, NTP, Eckert & Ziegler, SHINE Technologies, LLC, Eczacıbaşı-Monrol, IBA Worldwide, Global Medical Solutions, BWX Technologies. Inc, Institute of Isotopes, Coquí Radiopharmaceuticals Corp., Evergreen Theragnostics, Inc., Isotope JSC, and PharmaLogic Holdings Corp. among others

Market Definition

Radiopharmaceuticals contains a radioactive substance in association with one or more ingredients that is intended to diagnose, stage a disease, monitor treatment, or provide therapy. Radiopharmaceuticals include a group of radioactive agents used for either diagnostic or therapeutic interventions. These are the pharmaceuticals that incorporate a radionuclide. Most radiopharmaceuticals are a combination of a radioactive nuclide or radionuclide, and a biologically active molecule or drug that acts as a carrier and determines localization and biodistribution.

Global Radiopharmaceuticals Market Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

Driver

  • The Growing Demand for Radiopharmaeuticals in Diagnostics and Clinical Use 

Radiopharmaceuticals have become essential in helping to diagnose organs and treat pathological disorders. They are utilized in diagnostic imaging and radiotherapy. Diagnostic radiopharmaceuticals possess no pharmacological effects and their administration is also not considered to be associated with relevant clinical side effects.

The number of radiopharmaceuticals in clinical use is rapidly growing, thus, allowing the medical community better access to detail information on the characteristics of the different types of tumors. Radionuclides are also gaining importance by providing palliative and curative treatment for an increasing number of malignant diseases.

For Instance,

  • In April 2021, as per International Atomic Energy Agency  article, the radionuclides can be paired for therapeutic and diagnostic applications and have the potential for widespread production with established methods for separation and radiolabeling

Radiopharmaceuticals are used to diagnose complex diseases such as cancer and have been proven efficient in clinical use, which increases its demand and hence act as a driver for the global radiopharmaceuticals market.

Restraint

  • Stringent Regulations for Radiopharmaceuticals

Radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. Therefore, the various types of the government regulations for launching a product in the market are found to be a restraint. Every country has its own regulations and has different bodies for regulatory procedures. Stringent regulatory and product approval policies are expected to hinder the development of the global radiopharmaceuticals market.

The stringent regulations from the government authorities are necessary to safeguard the company's reputation, prevent products from being unreliable, and increase trust on the side of consumers. There are several stages of investment and testing to gain approval from the regulated authority for a new drug which is comprised of various phases, and each phase has different regulatory requirements.

The organization conducting the trial needs to comply with the required documentation by the specific regulatory authority of the concerned country, and it should mean to be safe and legal as per the country's policies and jurisdiction.

However, the stringent regulatory guidelines for regulating the radiopharmaceuticals in the market may hinder the market growth, and the withdrawals of the drug from the market due to complex regulation can negatively impact the market, which is expected to restrain the market growth.

Radiopharmaceuticals Market

Opportunity

  • The Rising Research and Development Expenditure of Radiopharmaceuticals

Technological advancements include enhancing the stability and strength of traditional pharmaceuticals. The biotechnology and pharma companies are continuously investing in research and development to offer innovative services for diagnostic medications to the customers and enhance their market presence. Radiopharmaceuticals play a dynamic role in clinical development. While the diagnostic industry is in a constant state of fluctuation due to the implementation of new technologies in the market, the pharmaceutical and biotechnology industries continue to increase due to enhanced investment in radiopharmaceuticals companies along with mergers and acquisitions adoption of innovation in imaging technologies to support clinical trials for various diseases.                 

The increasing research and development expenditure in pharmaceutical and biotechnological companies is acting as an opportunity for the growth of the global radiopharmaceuticals market.

For Instance,

  • In June 2022, as per NCBI article, the designing radiopharmaceuticals is a rigorous and complicated process that relies on many factors such as selecting the required radio nucleotide and its decay mode. These both impact the localization and utility of the radiopharmaceutical

Many governments allocate funds to support research in healthcare and medical fields, including radiopharmaceutical development. National institutes, such as the National Institutes of Health (NIH) in the United States, the European Union Framework Programme for Research and Innovation (Horizon Europe), and other government bodies, offer grants, and funding opportunities for researchers working on radiopharmaceuticals.

The rising research and development expenditure has encouraged the development of new products and high research oriented programs organized in the industry. The activities also develop new drugs and therapies to treat chronic diseases are expected to boost the global radiopharmaceuticals market.

Therefore, the increasing expenditure on research activities as per the growing investments in young companies, developments, expansion, innovation, and product launches, along with merger acquisitions are driving the growth of the market..

Challenge

  • High Cost of Development and Implementation of radiopharmaceuticals

Radiopharmaceuticals play an important role in healthcare facilities, providing safety and efficiency in pharmaceutical and biotechnology companies. They have excellent properties and some disadvantages at the same time. The radiopharmaceuticals are expected to grow due to advancements in technologies. However, several obstacles may prevent the market from realizing its full potential as radiopharmaceuticals are expensive to develop and implement, and the market may not be expanding rapidly. Thus, higher development and implementation costs and requirements for suitable surfaces are limiting the market growth, resulting in additional infrastructure and operational costs.

For Instance,

  • In September 2015, as per NCBI Article - The cost of radiopharmaceutical materials is highly expensive as compared to other resources employed in the nuclear medicine department. Hence, the inefficient utilization of these costly materials will lead to waste and more financial burden on the healthcare system

However, the overall financial cost for the underutilized or over utilized radiopharmaceutical materials due to inefficient utilization is expected to challenge the market growth

Recent Developments

  • In October 2023, IBA Launches AKURACY which is an integrated solution for cardiac pet imaging at eacvi meeting in Barcelona. The company believes and stated that this is a unique integrated solution for pet myocardial perfusion imaging
  • In April 2023, Lantheus and POINT Biopharma Announced FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the treatment of metastatic castration resistant prostate cancer. The company stated that the radioligand therapy is quickly becoming another pillar of cancer treatment.

Global Radiopharmaceuticals Market Market Scope

The global radiopharmaceuticals market is segmented into four notable segments such as type, application, source, and end user. The growth among segments help you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

Type

  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals

On the basis of type, the market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals.

Application

  • Diagnostic
  • Therapeutic

On the basis of application, the market is segmented into diagnostic and therapeutic.

Source

  • Nuclear Reactors
  • Cyclotrons

On the basis of source, the market is segmented into nuclear reactors and cyclotrons.

End User

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Others

On the basis of end user, the market is segmented into hospitals, diagnostic centers, cancer research institutes, ambulatory surgical centers, and others.

Radiopharmaceuticals Market

Global Radiopharmaceuticals Market Regional Analysis/Insights

The global radiopharmaceuticals market is segmented into four notable segments such as type, application, source and end user.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, China, Japan, India ,South Korea, Australia, Singapore, Thailand,  Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America Brazil, Argentina, Chile, Colombia, Peru, Venezuela, Ecuador and Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and rest of Middle East and Africa.

North America is expected to dominate the global radiopharmaceuticals market due to the increasing investment in healthcare sector, which is expected to boost the market growth. The U.S. is expected to dominate the North America region due to the rise in technological advancement in healthcare and treatment products. Germany is expected to dominate the Europe region due to the increasing demand from emerging markets and expansion. China is expected to dominate the Asia-Pacific region due to the increasing customer inclinations toward advanced technological processes.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Radiopharmaceuticals Market

Competitive Landscape and Global Radiopharmaceuticals Market Market Share Analysis

The global radiopharmaceuticals market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.

Some of the major market players operating in the global radiopharmaceuticals market are Cardinal Health, Advanced Accelerator Applications, A Novartis Company, Lantheus, Curium, GE HealthCare, Jubilant Radiopharma, A Jubilant Pharma Company, China lsotope & Radiation Corporation., Siemens Healthcare GmbH, Bracco, NTP, Eckert & Ziegler, SHINE Technologies, LLC, Eczacıbaşı-Monrol, IBA Worldwide, Global Medical Solutions, BWX Technologies. Inc, Institute of Isotopes, Coquí Radiopharmaceuticals Corp., Evergreen Theragnostics, Inc., Isotope JSC, PharmaLogic Holdings Corp. among others.


SKU-

TABLE 1 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 2 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 GLOBAL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 5 GLOBAL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 6 GLOBAL THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 7 GLOBAL THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 8 GLOBAL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 9 GLOBAL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 GLOBAL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 11 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 12 GLOBAL DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 GLOBAL DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 14 GLOBAL PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 15 GLOBAL SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 16 GLOBAL THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 GLOBAL THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 18 GLOBAL RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 19 GLOBAL NUCLEAR REACTORS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 20 GLOBAL CYCLOTRONS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 GLOBAL RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 22 GLOBAL HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 GLOBAL DIAGNOSTIC CENTERS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 24 GLOBAL CANCER RESEARCH INSTITUTES IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 GLOBAL AMBULATORY SURGICAL CENTERS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 GLOBAL OTHERS IN RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 GLOBAL RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 33 NORTH AMERICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 34 NORTH AMERICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 36 NORTH AMERICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 37 NORTH AMERICA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 40 NORTH AMERICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 41 NORTH AMERICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 43 NORTH AMERICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 44 NORTH AMERICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 46 NORTH AMERICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 47 NORTH AMERICA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 54 U.S. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 55 U.S. DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 56 U.S. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 57 U.S. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 58 U.S. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 59 U.S. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 60 U.S. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 61 U.S. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 62 U.S. THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 63 U.S. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 64 U.S. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 65 U.S. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 66 U.S. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 67 U.S. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 68 U.S. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 69 U.S. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 U.S. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 71 U.S. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 72 U.S. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 73 U.S. DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 U.S. PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 75 U.S. SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 U.S. THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 77 U.S. RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 78 U.S. RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 79 CANADA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 80 CANADA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 81 CANADA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 CANADA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 83 CANADA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 84 CANADA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 85 CANADA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 86 CANADA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 87 CANADA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 88 CANADA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 CANADA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 90 CANADA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 91 CANADA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 92 CANADA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 93 CANADA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 94 CANADA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 95 CANADA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 96 CANADA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 97 CANADA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 98 CANADA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 99 CANADA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 100 CANADA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 101 CANADA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 102 CANADA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 103 CANADA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 104 MEXICO RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 105 MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 106 MEXICO PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 107 MEXICO PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 108 MEXICO PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 109 MEXICO SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 110 MEXICO SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 111 MEXICO SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 112 MEXICO THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 MEXICO BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 114 MEXICO BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 115 MEXICO BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 116 MEXICO BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 117 MEXICO BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 118 MEXICO BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 119 MEXICO ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 MEXICO ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 121 MEXICO ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 122 MEXICO RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 123 MEXICO DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 124 MEXICO PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 125 MEXICO SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 126 MEXICO THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 127 MEXICO RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 128 MEXICO RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 129 EUROPE RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 130 EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 131 EUROPE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 132 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 133 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 134 EUROPE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 135 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 136 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 137 EUROPE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 138 EUROPE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 139 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 140 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 141 EUROPE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 142 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 144 EUROPE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 145 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 146 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 147 EUROPE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 148 EUROPE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 149 EUROPE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 150 EUROPE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 151 EUROPE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 152 EUROPE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 153 EUROPE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 154 EUROPE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 155 GERMANY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 156 GERMANY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 GERMANY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 158 GERMANY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 159 GERMANY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 160 GERMANY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 GERMANY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 162 GERMANY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 163 GERMANY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 GERMANY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 165 GERMANY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 166 GERMANY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 167 GERMANY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 GERMANY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 169 GERMANY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 170 GERMANY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 GERMANY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 172 GERMANY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 173 GERMANY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 GERMANY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 GERMANY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 GERMANY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 177 GERMANY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 178 GERMANY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 179 GERMANY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 180 U.K. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 181 U.K. DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 182 U.K. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 183 U.K. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 184 U.K. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 185 U.K. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 186 U.K. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 187 U.K. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 188 U.K. THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 189 U.K. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 190 U.K. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 191 U.K. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 192 U.K. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 U.K. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 194 U.K. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 195 U.K. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 196 U.K. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 197 U.K. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 198 U.K. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 199 U.K. DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 200 U.K. PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 201 U.K. SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 202 U.K. THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 203 U.K. RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 204 U.K. RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 205 FRANCE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 206 FRANCE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 207 FRANCE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 208 FRANCE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 209 FRANCE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 210 FRANCE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 211 FRANCE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 212 FRANCE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 213 FRANCE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 214 FRANCE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 215 FRANCE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 216 FRANCE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 217 FRANCE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 218 FRANCE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 219 FRANCE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 220 FRANCE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 221 FRANCE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 222 FRANCE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 223 FRANCE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 224 FRANCE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 225 FRANCE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 226 FRANCE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 227 FRANCE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 228 FRANCE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 229 FRANCE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 230 ITALY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 231 ITALY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 232 ITALY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 233 ITALY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 234 ITALY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 235 ITALY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 236 ITALY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 237 ITALY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 238 ITALY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 239 ITALY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 ITALY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 241 ITALY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 242 ITALY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 243 ITALY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 244 ITALY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 245 ITALY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 246 ITALY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 247 ITALY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 248 ITALY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 249 ITALY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 250 ITALY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 251 ITALY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 252 ITALY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 253 ITALY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 254 ITALY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 255 SPAIN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 256 SPAIN DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 257 SPAIN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 258 SPAIN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 259 SPAIN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 260 SPAIN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 261 SPAIN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 262 SPAIN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 263 SPAIN THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 264 SPAIN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 265 SPAIN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 266 SPAIN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 267 SPAIN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 268 SPAIN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 269 SPAIN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 270 SPAIN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 271 SPAIN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 272 SPAIN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 273 SPAIN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 274 SPAIN DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 275 SPAIN PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 276 SPAIN SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 277 SPAIN THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 278 SPAIN RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 279 SPAIN RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 280 BELGIUM RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 281 BELGIUM DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 282 BELGIUM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 283 BELGIUM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 284 BELGIUM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 285 BELGIUM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 286 BELGIUM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 287 BELGIUM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 288 BELGIUM THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 289 BELGIUM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 290 BELGIUM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 291 BELGIUM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 292 BELGIUM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 293 BELGIUM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 294 BELGIUM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 295 BELGIUM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 296 BELGIUM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 297 BELGIUM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 298 BELGIUM RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 299 BELGIUM DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 300 BELGIUM PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 301 BELGIUM SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 302 BELGIUM THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 303 BELGIUM RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 304 BELGIUM RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 305 POLAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 306 POLAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 307 POLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 308 POLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 309 POLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 310 POLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 311 POLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 312 POLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 313 POLAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 314 POLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 315 POLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 316 POLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 317 POLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 POLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 319 POLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 320 POLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 321 POLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 322 POLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 323 POLAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 324 POLAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 325 POLAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 326 POLAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 327 POLAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 328 POLAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 329 POLAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 330 RUSSIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 331 RUSSIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 332 RUSSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 333 RUSSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 334 RUSSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 335 RUSSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 336 RUSSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 337 RUSSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 338 RUSSIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 339 RUSSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 340 RUSSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 341 RUSSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 342 RUSSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 343 RUSSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 344 RUSSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 345 RUSSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 346 RUSSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 347 RUSSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 348 RUSSIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 RUSSIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 350 RUSSIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 351 RUSSIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 RUSSIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 RUSSIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 354 RUSSIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 355 NORWAY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 356 NORWAY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 357 NORWAY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 358 NORWAY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 359 NORWAY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 360 NORWAY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 361 NORWAY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 362 NORWAY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 363 NORWAY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 364 NORWAY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 365 NORWAY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 366 NORWAY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 367 NORWAY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 368 NORWAY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 369 NORWAY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 370 NORWAY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 371 NORWAY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 372 NORWAY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 373 NORWAY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 374 NORWAY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 375 NORWAY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 376 NORWAY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 377 NORWAY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 378 NORWAY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 379 NORWAY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 380 TURKEY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 381 TURKEY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 382 TURKEY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 383 TURKEY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 384 TURKEY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 385 TURKEY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 386 TURKEY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 387 TURKEY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 388 TURKEY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 389 TURKEY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 390 TURKEY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 391 TURKEY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 392 TURKEY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 393 TURKEY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 394 TURKEY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 395 TURKEY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 396 TURKEY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 397 TURKEY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 398 TURKEY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 399 TURKEY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 400 TURKEY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 401 TURKEY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 402 TURKEY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 403 TURKEY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 404 TURKEY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 405 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 406 AUSTRIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 407 AUSTRIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 408 AUSTRIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 409 AUSTRIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 410 AUSTRIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 411 AUSTRIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 412 AUSTRIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 413 AUSTRIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 414 AUSTRIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 415 AUSTRIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 416 AUSTRIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 417 AUSTRIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 418 AUSTRIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 419 AUSTRIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 420 AUSTRIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 421 AUSTRIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 422 AUSTRIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 423 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 424 AUSTRIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 425 AUSTRIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 426 AUSTRIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 427 AUSTRIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 428 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 429 AUSTRIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 430 IRELAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 431 IRELAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 432 IRELAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 433 IRELAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 434 IRELAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 435 IRELAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 436 IRELAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 437 IRELAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 438 IRELAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 439 IRELAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 440 IRELAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 441 IRELAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 442 IRELAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 443 IRELAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 444 IRELAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 445 IRELAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 446 IRELAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 447 IRELAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 448 IRELAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 449 IRELAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 450 IRELAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 451 IRELAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 452 IRELAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 453 IRELAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 454 IRELAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 455 HUNGARY RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 456 HUNGARY DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 457 HUNGARY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 458 HUNGARY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 459 HUNGARY PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 460 HUNGARY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 461 HUNGARY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 462 HUNGARY SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 463 HUNGARY THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 464 HUNGARY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 465 HUNGARY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 466 HUNGARY BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 467 HUNGARY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 468 HUNGARY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 469 HUNGARY BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 470 HUNGARY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 471 HUNGARY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 472 HUNGARY ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 473 HUNGARY RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 474 HUNGARY DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 475 HUNGARY PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 476 HUNGARY SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 477 HUNGARY THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 478 HUNGARY RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 479 HUNGARY RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 480 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 481 NETHERLANDS DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 482 NETHERLANDS PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 483 NETHERLANDS PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 484 NETHERLANDS PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 485 NETHERLANDS SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 486 NETHERLANDS SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 487 NETHERLANDS SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 488 NETHERLANDS THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 489 NETHERLANDS BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 490 NETHERLANDS BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 491 NETHERLANDS BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 492 NETHERLANDS BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 493 NETHERLANDS BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 494 NETHERLANDS BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 495 NETHERLANDS ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 496 NETHERLANDS ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 497 NETHERLANDS ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 498 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 499 NETHERLANDS DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 500 NETHERLANDS PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 501 NETHERLANDS SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 502 NETHERLANDS THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 503 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 504 NETHERLANDS RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 505 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 506 SWITZERLAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 507 SWITZERLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 508 SWITZERLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 509 SWITZERLAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 510 SWITZERLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 511 SWITZERLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 512 SWITZERLAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 513 SWITZERLAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 514 SWITZERLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 515 SWITZERLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 516 SWITZERLAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 517 SWITZERLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 518 SWITZERLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 519 SWITZERLAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP IN MBQ)

TABLE 520 SWITZERLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 521 SWITZERLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 522 SWITZERLAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 523 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 524 SWITZERLAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 525 SWITZERLAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 526 SWITZERLAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 527 SWITZERLAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 528 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 529 SWITZERLAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 530 REST OF EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 531 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 532 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 533 ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 534 ASIA-PACIFIC PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 535 ASIA-PACIFIC PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 536 ASIA-PACIFIC PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 537 ASIA-PACIFIC SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 538 ASIA-PACIFIC SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 539 ASIA-PACIFIC SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 540 ASIA-PACIFIC THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 541 ASIA-PACIFIC BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 542 ASIA-PACIFIC BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 543 ASIA-PACIFIC BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 544 ASIA-PACIFIC BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 545 ASIA-PACIFIC BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 546 ASIA-PACIFIC BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 547 ASIA-PACIFIC ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 548 ASIA-PACIFIC ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 549 ASIA-PACIFIC ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 550 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 551 ASIA-PACIFIC DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 552 ASIA-PACIFIC PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 553 ASIA-PACIFIC SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 554 ASIA-PACIFIC THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 555 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 556 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 557 CHINA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 558 CHINA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 559 CHINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 560 CHINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 561 CHINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 562 CHINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 563 CHINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 564 CHINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 565 CHINA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 566 CHINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 567 CHINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 568 CHINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 569 CHINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 570 CHINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 571 CHINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 572 CHINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 573 CHINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 574 CHINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 575 CHINA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 576 CHINA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 577 CHINA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 578 CHINA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 579 CHINA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 580 CHINA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 581 CHINA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 582 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 583 AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 584 AUSTRALIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 585 AUSTRALIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 586 AUSTRALIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 587 AUSTRALIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 588 AUSTRALIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 589 AUSTRALIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 590 AUSTRALIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 591 AUSTRALIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 592 AUSTRALIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 593 AUSTRALIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 594 AUSTRALIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 595 AUSTRALIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 596 AUSTRALIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 597 AUSTRALIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 598 AUSTRALIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 599 AUSTRALIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 600 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 601 AUSTRALIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 602 AUSTRALIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 603 AUSTRALIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 604 AUSTRALIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 605 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 606 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 607 JAPAN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 608 JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 609 JAPAN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 610 JAPAN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 611 JAPAN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 612 JAPAN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 613 JAPAN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 614 JAPAN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 615 JAPAN THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 616 JAPAN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 617 JAPAN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 618 JAPAN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 619 JAPAN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 620 JAPAN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 621 JAPAN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 622 JAPAN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 623 JAPAN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 624 JAPAN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 625 JAPAN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 626 JAPAN DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 627 JAPAN PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 628 JAPAN SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 629 JAPAN THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 630 JAPAN RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 631 JAPAN RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 632 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 633 SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 634 SOUTH KOREA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 635 SOUTH KOREA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 636 SOUTH KOREA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 637 SOUTH KOREA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 638 SOUTH KOREA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 639 SOUTH KOREA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 640 SOUTH KOREA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 641 SOUTH KOREA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 642 SOUTH KOREA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 643 SOUTH KOREA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 644 SOUTH KOREA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 645 SOUTH KOREA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 646 SOUTH KOREA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 647 SOUTH KOREA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 648 SOUTH KOREA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 649 SOUTH KOREA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 650 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 651 SOUTH KOREA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 652 SOUTH KOREA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 653 SOUTH KOREA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 654 SOUTH KOREA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 655 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 656 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 657 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 658 SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 659 SINGAPORE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 660 SINGAPORE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 661 SINGAPORE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 662 SINGAPORE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 663 SINGAPORE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 664 SINGAPORE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 665 SINGAPORE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 666 SINGAPORE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 667 SINGAPORE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 668 SINGAPORE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 669 SINGAPORE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 670 SINGAPORE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 671 SINGAPORE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 672 SINGAPORE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 673 SINGAPORE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 674 SINGAPORE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 675 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 676 SINGAPORE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 677 SINGAPORE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 678 SINGAPORE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 679 SINGAPORE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 680 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 681 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 682 INDIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 683 INDIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 684 INDIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 685 INDIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 686 INDIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 687 INDIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 688 INDIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 689 INDIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 690 INDIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 691 INDIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 692 INDIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 693 INDIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 694 INDIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 695 INDIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 696 INDIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 697 INDIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 698 INDIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 699 INDIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 700 INDIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 701 INDIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 702 INDIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 703 INDIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 704 INDIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 705 INDIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 706 INDIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 707 INDONESIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 708 INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 709 INDONESIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 710 INDONESIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 711 INDONESIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 712 INDONESIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 713 INDONESIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 714 INDONESIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 715 INDONESIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 716 INDONESIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 717 INDONESIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 718 INDONESIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 719 INDONESIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 720 INDONESIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 721 INDONESIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 722 INDONESIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 723 INDONESIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 724 INDONESIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 725 INDONESIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 726 INDONESIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 727 INDONESIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 728 INDONESIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 729 INDONESIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 730 INDONESIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 731 INDONESIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 732 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 733 PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 734 PHILIPPINES PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 735 PHILIPPINES PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 736 PHILIPPINES PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 737 PHILIPPINES SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 738 PHILIPPINES SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 739 PHILIPPINES SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 740 PHILIPPINES THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 741 PHILIPPINES BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 742 PHILIPPINES BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 743 PHILIPPINES BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 744 PHILIPPINES BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 745 PHILIPPINES BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 746 PHILIPPINES BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 747 PHILIPPINES ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 748 PHILIPPINES ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 749 PHILIPPINES ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 750 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 751 PHILIPPINES DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 752 PHILIPPINES PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 753 PHILIPPINES SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 754 PHILIPPINES THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 755 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 756 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 757 THAILAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 758 THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 759 THAILAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 760 THAILAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 761 THAILAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 762 THAILAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 763 THAILAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 764 THAILAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 765 THAILAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 766 THAILAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 767 THAILAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 768 THAILAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 769 THAILAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 770 THAILAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 771 THAILAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 772 THAILAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 773 THAILAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 774 THAILAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 775 THAILAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 776 THAILAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 777 THAILAND PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 778 THAILAND SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 779 THAILAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 780 THAILAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 781 THAILAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 782 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 783 MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 784 MALAYSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 785 MALAYSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 786 MALAYSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 787 MALAYSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 788 MALAYSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 789 MALAYSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 790 MALAYSIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 791 MALAYSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 792 MALAYSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 793 MALAYSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 794 MALAYSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 795 MALAYSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 796 MALAYSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 797 MALAYSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 798 MALAYSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 799 MALAYSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 800 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 801 MALAYSIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 802 MALAYSIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 803 MALAYSIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 804 MALAYSIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 805 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 806 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 807 VIETNAM RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 808 VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 809 VIETNAM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 810 VIETNAM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 811 VIETNAM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 812 VIETNAM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 813 VIETNAM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 814 VIETNAM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 815 VIETNAM THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 816 VIETNAM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 817 VIETNAM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 818 VIETNAM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 819 VIETNAM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 820 VIETNAM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 821 VIETNAM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 822 VIETNAM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 823 VIETNAM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 824 VIETNAM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 825 VIETNAM RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 826 VIETNAM DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 827 VIETNAM PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 828 VIETNAM SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 829 VIETNAM THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 830 VIETNAM RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 831 VIETNAM RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 832 REST OF ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 833 MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 834 MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 835 MIDDLE EAST AND AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 836 MIDDLE EAST AND AFRICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 837 MIDDLE EAST AND AFRICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 838 MIDDLE EAST AND AFRICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 839 MIDDLE EAST AND AFRICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 840 MIDDLE EAST AND AFRICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 841 MIDDLE EAST AND AFRICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 842 MIDDLE EAST AND AFRICA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 843 MIDDLE EAST AND AFRICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 844 MIDDLE EAST AND AFRICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 845 MIDDLE EAST AND AFRICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 846 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 847 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 848 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 849 MIDDLE EAST AND AFRICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 850 MIDDLE EAST AND AFRICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 851 MIDDLE EAST AND AFRICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 852 MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 853 MIDDLE EAST AND AFRICA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 854 MIDDLE EAST AND AFRICA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 855 MIDDLE EAST AND AFRICA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 856 MIDDLE EAST AND AFRICA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 857 MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 858 MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 859 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 860 SOUTH AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 861 SOUTH AFRICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 862 SOUTH AFRICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 863 SOUTH AFRICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 864 SOUTH AFRICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 865 SOUTH AFRICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 866 SOUTH AFRICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 867 SOUTH AFRICA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 868 SOUTH AFRICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 869 SOUTH AFRICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 870 SOUTH AFRICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 871 SOUTH AFRICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 872 SOUTH AFRICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 873 SOUTH AFRICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 874 SOUTH AFRICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 875 SOUTH AFRICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 876 SOUTH AFRICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 877 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 878 SOUTH AFRICA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 879 SOUTH AFRICA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 880 SOUTH AFRICA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 881 SOUTH AFRICA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 882 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 883 SOUTH AFRICA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 884 EGYPT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 885 EGYPT DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 886 EGYPT PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 887 EGYPT PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 888 EGYPT PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 889 EGYPT SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 890 EGYPT SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 891 EGYPT SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 892 EGYPT THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 893 EGYPT BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 894 EGYPT BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 895 EGYPT BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 896 EGYPT BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 897 EGYPT BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 898 EGYPT BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 899 EGYPT ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 900 EGYPT ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 901 EGYPT ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 902 EGYPT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 903 EGYPT DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 904 EGYPT PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 905 EGYPT SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 906 EGYPT THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 907 EGYPT RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 908 EGYPT RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 909 SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 910 SAUDI ARABIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 911 SAUDI ARABIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 912 SAUDI ARABIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 913 SAUDI ARABIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 914 SAUDI ARABIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 915 SAUDI ARABIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 916 SAUDI ARABIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 917 SAUDI ARABIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 918 SAUDI ARABIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 919 SAUDI ARABIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 920 SAUDI ARABIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 921 SAUDI ARABIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 922 SAUDI ARABIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 923 SAUDI ARABIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 924 SAUDI ARABIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 925 SAUDI ARABIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 926 SAUDI ARABIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 927 SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 928 SAUDI ARABIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 929 SAUDI ARABIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 930 SAUDI ARABIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 931 SAUDI ARABIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 932 SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 933 SAUDI ARABIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 934 U.A.E. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 935 U.A.E. DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 936 U.A.E. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 937 U.A.E. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 938 U.A.E. PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 939 U.A.E. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 940 U.A.E. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 941 U.A.E. SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 942 U.A.E. THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 943 U.A.E. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 944 U.A.E. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 945 U.A.E. BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 946 U.A.E. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 947 U.A.E. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 948 U.A.E. BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 949 U.A.E. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 950 U.A.E. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 951 U.A.E. ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 952 U.A.E. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 953 U.A.E. DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 954 U.A.E. PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 955 U.A.E. SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 956 U.A.E. THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 957 U.A.E. RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 958 U.A.E. RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 959 KUWAIT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 960 KUWAIT DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 961 KUWAIT PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 962 KUWAIT PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 963 KUWAIT PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 964 KUWAIT SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 965 KUWAIT SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 966 KUWAIT SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 967 KUWAIT THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 968 KUWAIT BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 969 KUWAIT BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 970 KUWAIT BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 971 KUWAIT BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 972 KUWAIT BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 973 KUWAIT BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 974 KUWAIT ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 975 KUWAIT ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 976 KUWAIT ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 977 KUWAIT RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 978 KUWAIT DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 979 KUWAIT PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 980 KUWAIT SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 981 KUWAIT THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 982 KUWAIT RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 983 KUWAIT RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 984 ISRAEL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 985 ISRAEL DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 986 ISRAEL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 987 ISRAEL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 988 ISRAEL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 989 ISRAEL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 990 ISRAEL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 991 ISRAEL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 992 ISRAEL THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 993 ISRAEL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 994 ISRAEL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 995 ISRAEL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 996 ISRAEL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 997 ISRAEL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 998 ISRAEL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 999 ISRAEL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1000 ISRAEL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1001 ISRAEL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1002 ISRAEL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1003 ISRAEL DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1004 ISRAEL PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1005 ISRAEL SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1006 ISRAEL THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1007 ISRAEL RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1008 ISRAEL RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1009 REST OF MIDDLE EAST AND AFRICA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1010 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 1011 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1012 SOUTH AMERICA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1013 SOUTH AMERICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1014 SOUTH AMERICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1015 SOUTH AMERICA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1016 SOUTH AMERICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1017 SOUTH AMERICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1018 SOUTH AMERICA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1019 SOUTH AMERICA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1020 SOUTH AMERICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1021 SOUTH AMERICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1022 SOUTH AMERICA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1023 SOUTH AMERICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1024 SOUTH AMERICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1025 SOUTH AMERICA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1026 SOUTH AMERICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1027 SOUTH AMERICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1028 SOUTH AMERICA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1029 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1030 SOUTH AMERICA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1031 SOUTH AMERICA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1032 SOUTH AMERICA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1033 SOUTH AMERICA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1034 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1035 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1036 BRAZIL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1037 BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1038 BRAZIL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1039 BRAZIL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1040 BRAZIL PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1041 BRAZIL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1042 BRAZIL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1043 BRAZIL SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1044 BRAZIL THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1045 BRAZIL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1046 BRAZIL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1047 BRAZIL BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1048 BRAZIL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1049 BRAZIL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1050 BRAZIL BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1051 BRAZIL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1052 BRAZIL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1053 BRAZIL ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1054 BRAZIL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1055 BRAZIL DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1056 BRAZIL PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1057 BRAZIL SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1058 BRAZIL THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1059 BRAZIL RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1060 BRAZIL RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1061 ARGENTINA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1062 ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1063 ARGENTINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1064 ARGENTINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1065 ARGENTINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1066 ARGENTINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1067 ARGENTINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1068 ARGENTINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1069 ARGENTINA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1070 ARGENTINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1071 ARGENTINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1072 ARGENTINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1073 ARGENTINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1074 ARGENTINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1075 ARGENTINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1076 ARGENTINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1077 ARGENTINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1078 ARGENTINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1079 ARGENTINA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1080 ARGENTINA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1081 ARGENTINA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1082 ARGENTINA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1083 ARGENTINA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1084 ARGENTINA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1085 ARGENTINA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1086 CHILE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1087 CHILE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1088 CHILE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1089 CHILE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1090 CHILE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1091 CHILE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1092 CHILE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1093 CHILE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1094 CHILE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1095 CHILE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1096 CHILE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1097 CHILE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1098 CHILE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1099 CHILE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1100 CHILE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1101 CHILE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1102 CHILE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1103 CHILE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1104 CHILE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1105 CHILE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1106 CHILE PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1107 CHILE SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1108 CHILE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1109 CHILE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1110 CHILE RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1111 COLOMBIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1112 COLOMBIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1113 COLOMBIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1114 COLOMBIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1115 COLOMBIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1116 COLOMBIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1117 COLOMBIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1118 COLOMBIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1119 COLOMBIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1120 COLOMBIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1121 COLOMBIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1122 COLOMBIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1123 COLOMBIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1124 COLOMBIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1125 COLOMBIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1126 COLOMBIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1127 COLOMBIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1128 COLOMBIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1129 COLOMBIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1130 COLOMBIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1131 COLOMBIA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1132 COLOMBIA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1133 COLOMBIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1134 COLOMBIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1135 COLOMBIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1136 PERU RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1137 PERU DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1138 PERU PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1139 PERU PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1140 PERU PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1141 PERU SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1142 PERU SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1143 PERU SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1144 PERU THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1145 PERU BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1146 PERU BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1147 PERU BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1148 PERU BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1149 PERU BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1150 PERU BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1151 PERU ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1152 PERU ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1153 PERU ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1154 PERU RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1155 PERU DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1156 PERU PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1157 PERU SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1158 PERU THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1159 PERU RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1160 PERU RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1161 VENEZUELA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1162 VENEZUELA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1163 VENEZUELA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1164 VENEZUELA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1165 VENEZUELA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1166 VENEZUELA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1167 VENEZUELA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1168 VENEZUELA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1169 VENEZUELA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1170 VENEZUELA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1171 VENEZUELA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1172 VENEZUELA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1173 VENEZUELA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1174 VENEZUELA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1175 VENEZUELA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1176 VENEZUELA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1177 VENEZUELA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1178 VENEZUELA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1179 VENEZUELA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1180 VENEZUELA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1181 VENEZUELA PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1182 VENEZUELA SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1183 VENEZUELA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1184 VENEZUELA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1185 VENEZUELA RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1186 ECUADOR RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1187 ECUADOR DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1188 ECUADOR PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1189 ECUADOR PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1190 ECUADOR PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1191 ECUADOR SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1192 ECUADOR SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1193 ECUADOR SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1194 ECUADOR THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1195 ECUADOR BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1196 ECUADOR BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1197 ECUADOR BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1198 ECUADOR BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1199 ECUADOR BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1200 ECUADOR BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1201 ECUADOR ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1202 ECUADOR ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (VOLUME IN MBQ)

TABLE 1203 ECUADOR ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (ASP PER MBQ)

TABLE 1204 ECUADOR RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1205 ECUADOR DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1206 ECUADOR PET IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1207 ECUADOR SPECT IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1208 ECUADOR THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1209 ECUADOR RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1210 ECUADOR RADIOPHARMACEUTICALS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1211 REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The major players in the Radiopharmaceuticals Market are Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), Bracco Imaging (Italy), Nordion (Canada), Advanced Accelerator Applications (France), etc.
The countries covered in the Radiopharmaceuticals Market are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
The global radiopharmaceuticals market is segmented into four notable segments such as type, application, source and end user.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, China, Japan, India ,South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America Brazil, Argentina, Chile, Colombia, Peru, Venezuela, Ecuador and Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and rest of Middle East and Africa.
North America is expected to dominate the global radiopharmaceuticals market due to the increasing investment in healthcare sector, which is expected to boost the market growth.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials